Market research
JHC.AU Japara Healthcare Limited
AU AUD Healthcare
Latest close
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 380M
- P/E ratio
- Not available
- Analyst target
- 1.05
- Dividend yield
- 0.0%
- Beta
- 2.27
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- AU000000JHC5
- Market cap
- 380M
- P/E ratio
- Not available
- Analyst target
- 1.05
- Dividend yield
- 0.0%
- Beta
- 2.27
About
About Japara Healthcare Limited
Japara Healthcare Limited, together with its subsidiaries, owns, develops, and operates residential aged care homes in Australia. It operates approximately 4,000 resident places across 50 homes, which include 33 homes in Victoria, seven homes in New South Wales, three homes in Queensland, five homes in South Australia, and two homes in Tasmania; and 180 independent living units across 5 retirement villages. The company was founded in 2005 and is based in Southbank, Australia. As of November 5, 2021, Japara Healthcare Limited operates as a subsidiary of Calvary Bruce Private Hospital Limited.
Research context
Japara Healthcare Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Care Facilities
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the JHC.AU discussion.
5 years, 6 months ago
Japara Healthcare Limited is currently in a long term uptrend where the price is trading 59.5% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.
Japara Healthcare Limited's total revenue rose by 15.4% to $213M since the same quarter in the previous year.
Its net income has dropped by 275.4% to $-10M since the same quarter in the previous year.
Finally, its free cash flow grew by 69.2% to $-9M since the same quarter in the previous year.
Based on the above factors, Japara Healthcare Limited gets an overall score of 4/5.